首页> 外文期刊>Kidney and blood pressure research >DCR2, a Cellular Senescent Molecule, Is a Novel Marker for Assessing Tubulointerstitial Fibrosis in Patients with Immunoglobulin A Nephropathy
【24h】

DCR2, a Cellular Senescent Molecule, Is a Novel Marker for Assessing Tubulointerstitial Fibrosis in Patients with Immunoglobulin A Nephropathy

机译:DCR2,一种细胞衰老分子,是一种评估免疫球蛋白A肾病患者肾小管间质纤维化的新标记

获取原文
获取外文期刊封面目录资料

摘要

Background/Aims: Stress-induced cell senescence, which contributes to cell cycle arrest and is independent of age, plays an important role in chronic kidney disease (CKD) progression. DcR2, as a senescent marker, exclusively expressed in senescent tubular epithelia. The objective of this study was to examine whether urinary DcR2 (uDcR2) could be a potential biomarker for tubulointerstitial fibrosis (TIF) in patients with immunoglobulin A nephropathy (IgAN). Methods: This study included 210 IgAN patients and 80 healthy volunteers, with uDcR2 levels measured using enzyme-linked immunosorbent assay. We examined the relationship among uDcR2/Cr levels, renal function, and pathological parameters, using regression analysis to identify risk factors for TIF and the area under the curve (AUC) approach to predict TIF. Renal DcR2 expression was quantified by immunohistochemistry. Co-expression of DcR2 with fibrotic markers (α-smooth muscle actin [α-SMA], collagen III) was analyzed by confocal microscopy. Results: Levels of uDcR2/Cr were significantly higher in IgAN patients and in those with more severe TIF, compared with healthy controls. Serum DcR2 levels were similar across groups. The proportion of IgAN patients with stages 1–2 CKD and T0 was highest among those with uDcR2/Cr 130 ng/g. In contrast, the majority of those with uDcR2/Cr 201 ng/g had stages 4–5 CKD and T2. Levels of uDcR2/Cr were positively associated with urinary albumin to creatinine ratio (ACR), urinary N-acetyl-β-D-glucosaminidase (uNAG)/Cr, and TIF scores and negatively associated with estimated glomerular filtration rate (eGFR). uDcR2/Cr, uNAG, ACR, and eGFR were independent predictors for TIF, with AUC of 0.907 for uDcR2/Cr. This AUC value was higher than that observed for eGFR, uNAG/Cr, or ACR. The sensitivity and specificity of uDcR2/Cr in predicting TIF were 87.0 and 80.5%, respectively. Moreover, uDcR2/Cr levels were positively associated with the percentage of renal DcR2 expression. Renal DcR2 co-localized with α-SMA and collagen III in the kidneys of IgAN patients. Conclusions: Levels of uDcR2/Cr were closely associated with the severity of TIF and renal function parameters. uDcR2/Cr represents a potential biomarker for predicting TIF in IgAN patients.
机译:背景/目的:应激诱导的细胞衰老有助于细胞周期停滞,并且与年龄无关,在慢性肾脏疾病(CKD)的进展中起重要作用。 DcR2,作为衰老标记,仅在衰老的肾小管上皮细胞中表达。这项研究的目的是检查尿DcR2(uDcR2)是否可能是免疫球蛋白A肾病(IgAN)患者肾小管间质纤维化(TIF)的潜在生物标志物。方法:本研究包括210名IgAN患者和80名健康志愿者,并通过酶联免疫吸附测定法测量uDcR2水平。我们检查了uDcR2 / Cr水平,肾功能和病理参数之间的关系,使用回归分析确定了TIF的危险因素以及预测TIF的曲线下面积(AUC)方法。肾DcR2表达通过免疫组织化学定量。通过共聚焦显微镜分析DcR2与纤维化标记物(α-平滑肌肌动蛋白[α-SMA],胶原蛋白III)的共表达。结果:与健康对照组相比,IgAN患者和TIF更为严重的患者中uDcR2 / Cr的水平明显更高。各组的血清DcR2水平相似。 uDcR2 / Cr <130 ng / g的那些患有1-2期CKD和T0分期的IgAN患者比例最高。相反,大多数uDcR2 / Cr> 201 ng / g的患者具有4-5 CKD和T2期。 uDcR2 / Cr水平与尿白蛋白/肌酐比(ACR),尿N-乙酰基-β-D-氨基葡萄糖苷酶(uNAG)/ Cr和TIF分数呈正相关,与估计的肾小球滤过率(eGFR)呈负相关。 uDcR2 / Cr,uNAG,ACR和eGFR是TIF的独立预测因子,uDcR2 / Cr的AUC为0.907。该AUC值高于eGFR,uNAG / Cr或ACR的值。 uDcR2 / Cr预测TIF的敏感性和特异性分别为87.0和80.5%。此外,uDcR2 / Cr水平与肾脏DcR2表达百分比呈正相关。在IgAN患者的肾脏中,肾脏DcR2与α-SMA和胶原III共定位。结论:uDcR2 / Cr的水平与TIF的严重程度和肾功能参数密切相关。 uDcR2 / Cr代表了预测IgAN患者TIF的潜在生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号